Investor Hub

Novavax, Inc. is a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases.

Latest quarterly earnings
Latest quarterly earnings
Latest investor presentation
Latest investor presentation
Latest clinical presentation
Latest clinical presentation
Latest publications
Our research
Annual report
Annual report
NASDAQ:NVAX
Loading data...
Stock details
Latest press releasesEvents & presentationsReports & financialsSEC filingsStock details & analyst coverage

SEC

Access filings by selecting the date range and type using the drop-down menus.

Loading data...

Why invest with us

We are a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases.

Learn more
Lisa Dunkle

Over my four-decade career, I’ve worked with biotech companies trying to solve significant health challenges and I firmly believe in the platform that we use to manufacture our recombinant protein. Our technology is key as we continue to respond to challenges posed by the SARS-CoV-2 endemic and other vaccine-preventable infectious diseases. 

Lisa Dunkle
Vice President, Global Medical Lead for Coronavirus Vaccine
Governance documents
Get notifications for investor updates

Sign up for notifications from Novavax including upcoming events, webcasts, research updates, daily stock closings, SEC filings, and more.

Go to email subscription
Investor inquiries

Shareholders seeking information can contact investor relations at (240) 268-2022 or email us at [email protected]

Novavax corporate policy prohibits any employees, other than designated spokespersons, from communicating with its investors.

Graph icon